A study to assess Remission and Response in Crohn'S Disease at Early and Late Treatment Points through prediction od Ustekinumab Trough Level
Latest Information Update: 09 Jul 2020
At a glance
- Drugs Ustekinumab (Primary) ; Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Pharmacokinetics
- 09 Jul 2020 New trial record
- 19 May 2020 Results published at Gastroenterology in conjunction with the Digestive Disease Week 2020